Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats. - Larsen,P.J.; Fledelius,C.; Knudsen,L.B.; Tang-Christensen,M. (Diabetes, 2001)